Bill Status of HB2743  99th General Assembly

Short Description:  INS CD-ABUSE DETERRENT OPIOIDS

House Sponsors
Rep. Emily McAsey - Sara Feigenholtz - John M. Cabello - Deb Conroy - Jehan Gordon-Booth, Camille Y. Lilly, Carol Ammons, John Bradley, Kathleen Willis, Natalie A. Manley, Jerry Costello, II, Laura Fine, Kelly M. Cassidy, Mary E. Flowers, Litesa E. Wallace, Jaime M. Andrade, Jr., Gregory Harris, Cynthia Soto, Michelle Mussman, Ann M. Williams, Frances Ann Hurley, Anna Moeller, Elaine Nekritz, Robert Rita, Monique D. Davis, Robyn Gabel, Will Guzzardi, Robert Martwick, Christian L. Mitchell, Martin J. Moylan, Mike Smiddy, Daniel J. Burke, Kelly M. Burke, Stephanie A. Kifowit, Emanuel Chris Welch, Silvana Tabares and Lawrence Walsh, Jr.

Last Action
DateChamber Action
  1/10/2017HouseSession Sine Die

Statutes Amended In Order of Appearance
5 ILCS 375/6.11
55 ILCS 5/5-1069.3
65 ILCS 5/10-4-2.3
105 ILCS 5/10-22.3f
215 ILCS 5/356z.23 new
215 ILCS 125/5-3from Ch. 111 1/2, par. 1411.2
215 ILCS 130/4003from Ch. 73, par. 1504-3
215 ILCS 165/10from Ch. 32, par. 604
305 ILCS 5/5-16.8


Synopsis As Introduced
Amends the Illinois Insurance Code, the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, the School Code, the Health Maintenance Organization Act, the Limited Health Service Organization Act, the Voluntary Health Services Plans Act, and the Illinois Public Aid Code. Provides that government programs and accident and health insurance policies providing coverage for prescription drugs shall provide coverage for abuse-deterrent opioid analgesic drugs as preferred drugs on their formulary, preferred drug list, or other lists of similar construct. Prohibits cost sharing for abuse-deterrent opioid analgesic drugs that exceeds the lowest cost sharing level applied to prescription drugs. Prohibits insurers from requiring require that a covered individual first use an opioid analgesic drug product without abuse-deterrence labeling claims before providing coverage for an abuse-deterrent opioid analgesic product. Provides that any prior authorization requirements or other utilization review measures for opioid analgesic drug products, and any service denials made under those, shall not require first use of non-abuse-deterrent opioid analgesic drug products in order to access opioid analgesic drug products with abuse-deterrent properties.

 Judicial Note (Admin Office of the Illinois Courts)
 This bill would neither increase nor decrease the number of judges needed in the State.

 Balanced Budget Note (Office of Management and Budget)
 Passage of this bill without an accompanying source of revenue will result in an unbalanced budget.

 State Debt Impact Note (Government Forecasting & Accountability)
 HB 2743 would not change the amount of authorization for any type of State-issued or State-supported bond, and, therefore, would not affect the level of State indebtedness.

 Pension Note (Government Forecasting & Accountability)
 HB 2743 will not impact any public pension fund or retirement system in Illinois.

 Housing Affordability Impact Note (Housing Development Authority)
 This bill will have no effect on the cost of constructing, purchasing, owning, or selling a single-family residence.

 Land Conveyance Appraisal Note (Dept. of Transportation)
 No land conveyances are included in this bill; therefore, there are no appraisals to be filed.

 Fiscal Note (Dept. of Healthcare & Family Services)
 The cost for the Department of Healthcare and Family Services would be $55 million at a 35% utilization shift.

 Correctional Note (Dept of Corrections)
 There are no penalty enhancements associated with this bill. The bill would have no fiscal or population impact on the Department of Corrections.

 Home Rule Note (Dept. of Commerce & Economic Opportunity)
 This bill does not pre-empt hole rule authority.

 State Mandates Fiscal Note (Dept. of Commerce & Economic Opportunity)
 This bill does not create a State mandate.

 Judicial Note, House Floor Amendment No. 3 (Admin Office of the Illinois Courts)
 This bill would neither increase nor decrease the number of judges needed in the State.

 Fiscal Note, House Floor Amendment No. 3 (Dept. of Central Management Services)
 The Department of Central Management Services has contacted the vendor, CVS Caremark to conduct the financial analysis. CMS does not retain that level of detail. The following is the summary of impact from CVS: (1) The annualized cost impact if 10% of non-abuse deterrent prescriptions move to the abuse-deterrent formulation is estimated at $6.005.041; (2) The annualized cost impact if 35% of non-abuse deterrent prescriptions move to the abuse-deterrent formulation is estimated at $21.017.646; (3) The annualized cost impact if 50% of non-abuse deterrent prescriptions move to the abuse-deterrent formulation is estimated at $30.025.209.

 Fiscal Note, House Floor Amendment No. 3 (Dept. of Healthcare & Family Services)
 Providing coverage for these abuse-deterrent drugs to the managed care population will have a fiscal impact between $69 million (with 25% of users shifting to abuse-deterrent formulations) and $217 million (with a 100% shift to abuse-deterrent formulations). This cost would be added to the MCO capitation payments; however not eligible for federal matching funds.

 State Mandates Fiscal Note, House Floor Amendment No. 3 (Dept. of Commerce & Economic Opportunity)
 This bill does not create a State mandate.

Actions 
DateChamber Action
  2/20/2015HouseFiled with the Clerk by Rep. Sara Feigenholtz
  2/20/2015HouseFirst Reading
  2/20/2015HouseReferred to Rules Committee
  3/2/2015HouseAssigned to Human Services Committee
  3/18/2015HouseDo Pass / Short Debate Human Services Committee; 009-003-000
  3/18/2015HousePlaced on Calendar 2nd Reading - Short Debate
  3/19/2015HouseAdded Chief Co-Sponsor Rep. Emily McAsey
  3/19/2015HouseAdded Co-Sponsor Rep. Camille Y. Lilly
  3/19/2015HouseAdded Co-Sponsor Rep. Carol Ammons
  3/19/2015HouseAdded Co-Sponsor Rep. John Bradley
  3/19/2015HouseAdded Co-Sponsor Rep. Kathleen Willis
  3/19/2015HouseAdded Co-Sponsor Rep. Natalie A. Manley
  3/19/2015HouseAdded Co-Sponsor Rep. Jerry Costello, II
  3/19/2015HouseAdded Co-Sponsor Rep. Laura Fine
  3/19/2015HouseAdded Co-Sponsor Rep. Kelly M. Cassidy
  3/19/2015HouseAdded Co-Sponsor Rep. Mary E. Flowers
  3/19/2015HouseAdded Co-Sponsor Rep. Litesa E. Wallace
  3/19/2015HouseAdded Co-Sponsor Rep. Jaime M. Andrade, Jr.
  3/19/2015HouseAdded Co-Sponsor Rep. Gregory Harris
  3/19/2015HouseAdded Co-Sponsor Rep. Cynthia Soto
  3/19/2015HouseAdded Co-Sponsor Rep. Daniel V. Beiser
  3/19/2015HouseAdded Co-Sponsor Rep. Michelle Mussman
  3/19/2015HouseAdded Co-Sponsor Rep. Ann M. Williams
  3/19/2015HouseAdded Co-Sponsor Rep. Frances Ann Hurley
  3/19/2015HouseAdded Co-Sponsor Rep. Anna Moeller
  3/19/2015HouseAdded Co-Sponsor Rep. Elaine Nekritz
  3/19/2015HouseAdded Co-Sponsor Rep. Michael J. Zalewski
  3/19/2015HouseAdded Co-Sponsor Rep. Robert Rita
  3/19/2015HouseAdded Co-Sponsor Rep. Monique D. Davis
  3/19/2015HouseRemoved Co-Sponsor Rep. Michael J. Zalewski
  3/19/2015HouseRemoved Co-Sponsor Rep. Daniel V. Beiser
  3/24/2015HouseFiscal Note Requested by Rep. Ron Sandack
  3/27/2015HouseState Mandates Fiscal Note Requested by Rep. Sara Feigenholtz
  3/27/2015HouseBalanced Budget Note Requested by Rep. Sara Feigenholtz
  3/27/2015HouseCorrectional Note Requested by Rep. Sara Feigenholtz
  3/27/2015HouseHome Rule Note Requested by Rep. Sara Feigenholtz
  3/27/2015HouseHousing Affordability Impact Note Requested by Rep. Sara Feigenholtz
  3/27/2015HouseJudicial Note Requested by Rep. Sara Feigenholtz
  3/27/2015HouseLand Conveyance Appraisal Note Requested by Rep. Sara Feigenholtz
  3/27/2015HousePension Note Requested by Rep. Sara Feigenholtz
  3/27/2015HouseState Debt Impact Note Requested by Rep. Sara Feigenholtz
  3/30/2015HouseJudicial Note Filed
  3/30/2015HouseBalanced Budget Note Filed
  4/1/2015HouseState Debt Impact Note Filed
  4/1/2015HousePension Note Filed
  4/1/2015HouseHousing Affordability Impact Note Filed
  4/9/2015HouseLand Conveyance Appraisal Note Filed
  4/10/2015HouseFiscal Note Filed
  4/14/2015HouseCorrectional Note Filed
  4/14/2015HouseHome Rule Note Filed
  4/14/2015HouseState Mandates Fiscal Note Filed
  4/17/2015HouseAdded Chief Co-Sponsor Rep. Deb Conroy
  4/17/2015HouseAdded Co-Sponsor Rep. Robyn Gabel
  4/17/2015HouseAdded Co-Sponsor Rep. Linda Chapa LaVia
  4/17/2015HouseAdded Co-Sponsor Rep. Marcus C. Evans, Jr.
  4/17/2015HouseAdded Co-Sponsor Rep. Will Guzzardi
  4/17/2015HouseAdded Co-Sponsor Rep. Robert Martwick
  4/17/2015HouseAdded Co-Sponsor Rep. Christian L. Mitchell
  4/17/2015HouseAdded Co-Sponsor Rep. Martin J. Moylan
  4/17/2015HouseRemoved Co-Sponsor Rep. Linda Chapa LaVia
  4/17/2015HouseRemoved Co-Sponsor Rep. Marcus C. Evans, Jr.
  4/20/2015HouseAdded Co-Sponsor Rep. Mike Smiddy
  4/20/2015HouseAdded Co-Sponsor Rep. Jay Hoffman
  4/20/2015HouseAdded Co-Sponsor Rep. Daniel J. Burke
  4/20/2015HouseChief Sponsor Changed to Rep. Emily McAsey
  4/20/2015HouseRemove Chief Co-Sponsor Rep. Emily McAsey
  4/20/2015HouseAdded Co-Sponsor Rep. Kelly M. Burke
  4/20/2015HouseAdded Chief Co-Sponsor Rep. Sara Feigenholtz
  4/21/2015HouseAdded Co-Sponsor Rep. Stephanie A. Kifowit
  4/21/2015HouseRemoved Co-Sponsor Rep. Jay Hoffman
  4/22/2015HouseAdded Co-Sponsor Rep. Emanuel Chris Welch
  4/22/2015HouseSecond Reading - Short Debate
  4/22/2015HouseHeld on Calendar Order of Second Reading - Short Debate
  4/24/2015HousePlaced on Calendar Order of 3rd Reading - Short Debate
  4/24/2015HouseThird Reading - Consideration Postponed
  4/24/2015HousePlaced on Calendar - Consideration Postponed
  4/24/2015HouseAdded Chief Co-Sponsor Rep. Jehan Gordon-Booth
  4/24/2015HouseAdded Co-Sponsor Rep. Silvana Tabares
  4/24/2015HouseRule 19(a) / Re-referred to Rules Committee
  5/25/2015HouseApproved for Consideration Rules Committee; 003-000-000
  5/25/2015HouseFinal Action Deadline Extended-9(b) May 31, 2015
  5/25/2015HouseThird Reading - Consideration Postponed
  5/25/2015HousePlaced on Calendar - Consideration Postponed
  5/28/2015HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Emily McAsey
  5/28/2015HouseHouse Floor Amendment No. 1 Referred to Rules Committee
  5/31/2015HouseRule 19(a) / Re-referred to Rules Committee
  5/16/2016HouseApproved for Consideration Rules Committee; 003-000-000
  5/16/2016HousePlaced on Calendar - Consideration Postponed
  5/16/2016HouseFinal Action Deadline Extended-9(b) May 27, 2016
  5/17/2016HouseHouse Floor Amendment No. 2 Filed with Clerk by Rep. Emily McAsey
  5/17/2016HouseHouse Floor Amendment No. 2 Referred to Rules Committee
  5/18/2016HouseHouse Floor Amendment No. 3 Filed with Clerk by Rep. Emily McAsey
  5/18/2016HouseHouse Floor Amendment No. 3 Referred to Rules Committee
  5/19/2016HouseHouse Floor Amendment No. 3 Rules Refers to Human Services Committee
  5/19/2016HouseAdded Chief Co-Sponsor Rep. John M. Cabello
  5/25/2016HouseHouse Floor Amendment No. 3 Recommends Be Adopted Human Services Committee; 009-005-000
  5/25/2016HouseHouse Floor Amendment No. 3 Fiscal Note Requested as Amended by Rep. Ed Sullivan
  5/25/2016HouseHouse Floor Amendment No. 3 State Mandates Fiscal Note Requested as Amended by Rep. Ed Sullivan
  5/25/2016HouseHouse Floor Amendment No. 3 Judicial Note Requested as Amended by Rep. Ed Sullivan
  5/25/2016HouseHouse Floor Amendment No. 3 Judicial Note Filed as Amended
  5/25/2016HouseAdded Co-Sponsor Rep. Lawrence Walsh, Jr.
  5/27/2016HouseHouse Floor Amendment No. 3 Fiscal Note Filed as Amended
  5/27/2016HouseHouse Floor Amendment No. 3 Fiscal Note Filed as Amended
  5/27/2016HouseFinal Action Deadline Extended-9(b) May 31, 2016
  5/31/2016HouseHouse Floor Amendment No. 3 State Mandates Fiscal Note Filed as Amended
  5/31/2016HouseRule 19(a) / Re-referred to Rules Committee
  1/10/2017HouseSession Sine Die